Ucb Sa Adr Stock Analysis

UCBJY Stock  USD 58.22  1.22  2.14%   
UCB SA ADR is undervalued with Real Value of 63.67 and Hype Value of 57.0. The main objective of UCB SA pink sheet analysis is to determine its intrinsic value, which is an estimate of what UCB SA ADR is worth, separate from its market price. There are two main types of UCB SA's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect UCB SA's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of UCB SA's stock to identify patterns and trends that may indicate its future price movements.
The UCB SA pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. UCB SA is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. UCB Pink Sheet trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and UCB SA's ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UCB SA ADR. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in inflation.

UCB Pink Sheet Analysis Notes

The company has Price to Book (P/B) ratio of 1.55. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. UCB SA ADR last dividend was issued on the 29th of April 2022. UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company was incorporated in 1925 and is headquartered in Brussels, Belgium. UCB S operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8600 people.The quote for UCB SA ADR is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call JeanChristophe Tellier at 32 2 559 99 99 or visit https://www.ucb.com.

UCB Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 15.86 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate UCB SA's market, we take the total number of its shares issued and multiply it by UCB SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

UCB Profitablity

UCB SA's profitability indicators refer to fundamental financial ratios that showcase UCB SA's ability to generate income relative to its revenue or operating costs. If, let's say, UCB SA is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, UCB SA's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of UCB SA's profitability requires more research than a typical breakdown of UCB SA's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.19 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.19.

Technical Drivers

As of the 18th of March 2024, UCB SA owns the Mean Deviation of 1.33, standard deviation of 1.82, and Market Risk Adjusted Performance of 0.5692. Compared to fundamental indicators, the technical analysis model makes it possible for you to check helpful technical drivers of UCB SA ADR, as well as the relationship between them. Strictly speaking, you can use this information to find out if the entity will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We are able to break down nineteen technical drivers for UCB SA, which can be compared to its peers in the sector. Please validate UCB SA ADR mean deviation, information ratio, as well as the relationship between the Information Ratio and downside variance to decide if UCB SA ADR is priced fairly, providing market reflects its prevailing price of 58.22 per share. Given that UCB SA ADR has jensen alpha of 0.3782, we advise you to double-check UCB SA's latest market performance to make sure the company can sustain itself in the future.

UCB SA ADR Price Movement Analysis

null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. UCB SA middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for UCB SA ADR. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

UCB SA Predictive Daily Indicators

UCB SA intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of UCB SA pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

UCB SA Forecast Models

UCB SA's time-series forecasting models are one of many UCB SA's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary UCB SA's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About UCB Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how UCB SA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling UCB shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as UCB SA. By using and applying UCB Pink Sheet analysis, traders can create a robust methodology for identifying UCB entry and exit points for their positions.
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company was incorporated in 1925 and is headquartered in Brussels, Belgium. UCB S operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8600 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding UCB SA to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Fundamentals Comparison Now

   

Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Module
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UCB SA ADR. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in inflation.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for UCB Pink Sheet analysis

When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Money Managers
Screen money managers from public funds and ETFs managed around the world
Please note, there is a significant difference between UCB SA's value and its price as these two are different measures arrived at by different means. Investors typically determine if UCB SA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UCB SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.